Abstract
to Robert and Tim Fischell, described an "intraarterial stent with the capability to inhibit intimal hyperplasia." 1 The proponents of this patent went on to say in their proposal: "Since radiation from a radioisotope source is capable of selectively inhibiting the growth of hyperproliferating cells as compared with normal cells, a radioisotope material which forms part of the stent can be used to decrease the rate of arterial reclosure.The radioisotope could be placed inside the stent, alloyed into the metal from which the stent is made, or preferably, it can be coated onto the stent's exterior surface."So began the story of the radioactive stent.Eight years and several animal species later, we are becoming aware of the bright and dark sides of this treatment modality in the human model.
Keywords
Related Publications
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
In patients receiving intravenous t-PA for acute ischemic stroke due to occlusions in the proximal anterior intracranial circulation, thrombectomy with a stent retriever within ...
Controlled trial of high-versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease
Percutaneous transluminal angioplasty of aortoiliac and femoropopliteal atherosclerotic lesions can provide long-lasting hemodynamic improvement. High-dose aspirin is commonly p...
A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery Stenting
As compared with aspirin alone and a combination of aspirin and warfarin, treatment with aspirin and ticlopidine resulted in a lower rate of stent thrombosis, although there wer...
Publication Info
- Year
- 2000
- Type
- review
- Volume
- 101
- Issue
- 1
- Pages
- 3-7
- Citations
- 95
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1161/01.cir.101.1.3